BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3135316)

  • 21. Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-gamma.
    Gerrard TL; Dyer DR; Zoon KC; zur Nedden D; Siegel JP
    J Immunol; 1988 May; 140(10):3450-5. PubMed ID: 2966196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
    Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
    Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
    Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
    J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IFN-gamma-regulated expression of a differentiation antigen of human cells.
    Real FX; Carrato A; Schuessler MH; Welt S; Oettgen HF
    J Immunol; 1988 Mar; 140(5):1571-6. PubMed ID: 3126230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon.
    Matsui M; Temponi M; Ferrone S
    J Immunol; 1987 Sep; 139(6):2088-95. PubMed ID: 3114385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.
    Czarniecki CW; Chiu HH; Wong GH; McCabe SM; Palladino MA
    J Immunol; 1988 Jun; 140(12):4217-23. PubMed ID: 3131428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of HLA class II genes by IFN-gamma is transcriptional and requires a trans-acting protein.
    Amaldi I; Reith W; Berte C; Mach B
    J Immunol; 1989 Feb; 142(3):999-1004. PubMed ID: 2492334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
    Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
    Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
    Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
    J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA DR, DQ, and DP antigen expression in rheumatoid synovial cells: a biochemical and quantitative study.
    Teyton L; Lotteau V; Turmel P; Arenzana-Seisdedos F; Virelizier JL; Pujol JP; Loyau G; Piatier-Tonneau D; Auffray C; Charron DJ
    J Immunol; 1987 Mar; 138(6):1730-8. PubMed ID: 3102596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon.
    Wang D; Levasseur-Acker GM; Jankowski R; Kanny G; Moneret-Vautrin DA; Charron D; Lockhart A; Swierczewski E
    Clin Exp Allergy; 1997 Mar; 27(3):306-14. PubMed ID: 9088657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of MHC class II expression in human cells by dexamethasone.
    Schwiebert LM; Schleimer RP; Radka SF; Ono SJ
    Cell Immunol; 1995 Oct; 165(1):12-9. PubMed ID: 7671315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
    Gomi K; Akinaga S; Oka T; Morimoto M
    Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
    Robbins PA; Maino VC; Warner NL; Brodsky FM
    J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma.
    Propper DJ; Chao D; Braybrooke JP; Bahl P; Thavasu P; Balkwill F; Turley H; Dobbs N; Gatter K; Talbot DC; Harris AL; Ganesan TS
    Clin Cancer Res; 2003 Jan; 9(1):84-92. PubMed ID: 12538455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel IFN-gamma regulated human melanoma associated antigen gp33-38 defined by monoclonal antibody Me14/D12. I. Identification and immunochemical characterization.
    Giuffré L; Isler P; Mach JP; Carrel S
    J Immunol; 1988 Sep; 141(6):2072-8. PubMed ID: 3139751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer.
    Yoshino I; Peoples GE; Goedegebuure PS; Maziarz R; Eberlein TJ
    J Immunol; 1994 Mar; 152(5):2393-400. PubMed ID: 8133050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.